Sentinel node mapping in endometrial cancer
Journal of Gynecologic Oncology · 2024 · 35 (1)
DOI: 10.3802/jgo.2024.35.e29 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gynecologic Oncology, 2024. Verfasst von Giorgio Bogani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy. Hauptthemen laut MEDLINE: Sentinel Lymph Node, Endometrial Neoplasms. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Nodal status is one of the most important prognostic factors for patients with apparent early stage endometrial cancer. The role of retroperitoneal staging in endometrial cancer is controversial. Nodal status provides useful prognostic data, and allows to tailor the need of postoperative treatments. However, two independent randomized trials showed that the execution of (pelvic) lymphadenectomy increases the risk of having surgery-related complication without improving patients' outcomes. Sentinel node mapping aims to achieve data regarding nodal status without increasing morbidity. Sentinel node mapping is the removal of first (clinically negative) lymph nodes draining the uterus. Several studies suggested that sentinel node mapping is not inferior to lymphadenectomy in identifying patients with nodal disease. More importantly, thorough ultrastaging sentinel node mapping allows the detection of low volume disease (micrometastases and isolated tumor cells), that are not always detectable via conventional pathological examination. Therefore, the adoption of sentinel node mapping guarantees a higher identification of patients with nodal disease than lymphadenectomy. Further evidence is needed to assess the value of various adjuvant strategies in patients with low volume disease and to tailor those treatments also on the basis of the molecular and genomic characterization of endometrial tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.
- Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy. giorgiobogani@yahoo.it.
- Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Rome, Italy.
- Unit of Gynecologic Oncology, Department of Experimental Clinical Oncology, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
ORCID-Profile: Giorgio Bogani, Andrea Giannini, Enrico Vizza, Violante Di Donato, Francesco Raspagliesi
Zitieren
APA
Bogani, G., Giannini, A., Vizza, E., Di Donato, V., & Raspagliesi, F. (2024). Sentinel node mapping in endometrial cancer. Journal of Gynecologic Oncology, 35(1). https://doi.org/10.3802/jgo.2024.35.e29
Vancouver
Bogani G, Giannini A, Vizza E, Di Donato V, Raspagliesi F. Sentinel node mapping in endometrial cancer. Journal of Gynecologic Oncology. 2024;35(1). doi:10.3802/jgo.2024.35.e29
BibTeX
@article{Bogani2024,
author = {Bogani, Giorgio and Giannini, Andrea and Vizza, Enrico and Di Donato, Violante and Raspagliesi, Francesco},
title = {Sentinel node mapping in endometrial cancer},
journal = {Journal of Gynecologic Oncology},
year = {2024},
volume = {35},
number = {1},
doi = {10.3802/jgo.2024.35.e29}
}
EUVIMED